QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mignot, E. Articles by Dement, W. C. Search for Related Content PubMed PubMed Citation Articles by Mignot, E. Articles by Dement, W. C.

 Previous Article  |  Next Article 

Journal of Neuroscience, Vol 13, 1057-1064, Copyright © 1993 by Society for Neuroscience

ARTICLE

Heterozygosity at the canarc-1 locus can confer susceptibility for narcolepsy: induction of cataplexy in heterozygous asymptomatic dogs after administration of a combination of drugs acting on monoaminergic and cholinergic systems

E Mignot, S Nishino, LH Sharp, J Arrigoni, JM Siegel, MS Reid, DM Edgar, RD Ciaranello and WC Dement
Stanford University Sleep Disorders Center, Palo Alto, California 94304.

Narcolepsy is a genetically determined disorder of sleep characterized by excessive daytime sleepiness and abnormal manifestations of REM sleep that affects both humans and animals. Although its exact pathophysiologic mechanisms remain undetermined, recent experiments have demonstrated that in both humans and canines, susceptibility genes are linked with immune-related genes. A striking difference, however, is that the genes thought to be involved in the human pathology are autosomal dominant, whereas canine narcolepsy in Dobermans is transmitted as a single autosomal recessive gene with full penetrance (canarc-1). In this study, we have examined the development of narcoleptic symptoms in homozygous narcoleptic, heterozygous, and control Dobermans. Animals were behaviorally observed until 5 months of age and then treated at weekly intervals with cataplexy-inducing compounds that act on cholinergic or monoaminergic systems (alone and in combination). Our data indicate that cataplexy can be induced in 6- month-old asymptomatic heterozygous animals, but not in control canines, with a combination of drugs that act on the monoaminergic and cholinergic systems. This demonstrates that disease susceptibility may be carried by heterozygosity at the canarc-1 locus. Our data further suggest that cataplexy, a model of REM sleep atonia, is centrally regulated by a balance of activity between cholinergic and monoaminergic neurons.

This article has been cited by other articles:

				J. M. Siegel, R. Nienhuis, S. Gulyani, S. Ouyang, M. F. Wu, E. Mignot, R. C. Switzer, G. McMurry, and M. Cornford Neuronal Degeneration in Canine Narcolepsy J. Neurosci., January 1, 1999; 19(1): 248 - 257. [Abstract] [Full Text] [PDF]

				H. Kadotani, J. Faraco, and E. Mignot Genetic Studies in the Sleep Disorder Narcolepsy Genome Res., May 1, 1998; 8(5): 427 - 434. [Abstract] [Full Text]

				M. Tafti, S. Nishino, M. S. Aldrich, W. Liao, W. C. Dement, and E. Mignot Major Histocompatibility Class II Molecules in the CNS: Increased Microglial Expression at the Onset of Narcolepsy in a Canine Model J. Neurosci., August 1, 1996; 16(15): 4588 - 4595. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help